CapsoVision (CV) Equity Ratio (2024 - 2025)
CapsoVision's (CV) quarterly Equity Ratio came in at 0.73 in Q4 2025, up 109.47% year-on-year from 0.35 in Q4 2024, and down 8.36% quarter-over-quarter from 0.8 in Q3 2025.
CapsoVision (CV) Equity Ratio (2024 - 2025) Analysis & Trends
CapsoVision has disclosed Equity Ratio across 2 years of filings, most recently posting 0.73 for Q4 2025.
- Equity Ratio for Q4 2025 came in at 0.73, up 109.47% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.73 (up 109.47% YoY), and the FY2025 annual result was 0.73, up 109.47% from the prior year.
- Equity Ratio came in at 0.73 for Q4 2025 at CapsoVision, down from 0.8 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.8 in Q3 2025 to a low of 14.56 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.78 |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 0.29 |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.42 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 0.45 |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 0.67 |
| 10 | CapsoVision | 176.55 Mn | 166.44 Mn | 1.95 Mn | 0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.73 |
| Sep 30, 2025 | 0.80 |
| Jun 30, 2025 | -14.56 |
| Dec 31, 2024 | -7.71 |